Table 4.

Multivariable model of risk of TA-TMA in SCD

VariableOR95% CIP value
SCD 12.22 1.15 to 129.5 .038 
Non-SCD REF   
Haploidentical 2.18 0.255 to 18.698 .48 
MSD REF   
Viral infection 1.79 0.27 to 11.88 .55 
No viral infection REF   
Myeloablation 1.31 0.95 to 18.09 .84 
Nonmyeloablation REF   
Grade 1-4 acute GVHD 7.46 1.02 to 54.5 .05 
Grade 0 GVHD REF   
Cell source, UC <0.0001 <0.001 to >999.999 .96 
Cell source, PBSC <0.0001 <0.0001 to 999.999 .98 
Cell source, bone marrow transplant REF   
VariableOR95% CIP value
SCD 12.22 1.15 to 129.5 .038 
Non-SCD REF   
Haploidentical 2.18 0.255 to 18.698 .48 
MSD REF   
Viral infection 1.79 0.27 to 11.88 .55 
No viral infection REF   
Myeloablation 1.31 0.95 to 18.09 .84 
Nonmyeloablation REF   
Grade 1-4 acute GVHD 7.46 1.02 to 54.5 .05 
Grade 0 GVHD REF   
Cell source, UC <0.0001 <0.001 to >999.999 .96 
Cell source, PBSC <0.0001 <0.0001 to 999.999 .98 
Cell source, bone marrow transplant REF   
View Large
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal